Difference between revisions of "People:S Beck"
From Bioinformatics Lab
| Line 6: | Line 6: | ||
*'''B.Sc.''', ''Seoul National University'', Department of Animal Biotechnology (03/1999 - 02/2004).<br /> | *'''B.Sc.''', ''Seoul National University'', Department of Animal Biotechnology (03/1999 - 02/2004).<br /> | ||
<br /> | <br /> | ||
| + | *'''Contact''': beck310(at)gmail | ||
| + | |||
| + | ==Research Interests== | ||
| + | *Tumor Development, Cancer Genomics, Systems Biology | ||
| + | |||
| + | ==Publications== | ||
| + | * '''Beck S''', Jin X, Sohn YW, Kim JK, Kim SH, Yin J, Pian X, Kim SC, Nam DH, Choi YJ, Kim H. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression. Mol Cells. 2010 Dec 24. | ||
| + | * Jin X*, '''Beck S'''*, Sohn YW, Kim JK, Kim SH, Yin J, Pian X, Kim SC, Choi YJ, Kim H. (*Equal contribution) Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor. Exp Mol Med. 2010 Aug 31;42(8):574-82. | ||
| + | * Jin X, Jeon HY, Joo KM, Kim JK, Jin J, Kim SH, Kang BG, '''Beck S''', Lee SJ, Kim JK, Park AK, Park WY, Choi YJ, Nam DH, Kim H. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 2011 Mar 1. [Epub ahead of print] | ||
| + | * Yin J, Jin X, '''Beck S''', Kang DH, Hong Z, Li Z, Jin Y, Zhang Q, Choi YJ, Kim SC, Kim H. In vitro myogenic and adipogenic differentiation model of genetically engineered bovine embryonic fibroblast cell lines. Biotechnol Lett. 2010 Feb;32(2):195-202. | ||
| + | * Jin X, Kim JG, Oh MJ, Oh HY, Sohn YW, Pian X, Yin JL, '''Beck S''', Lee N, Son J, Kim H, Yan C, Wang JH, Choi YJ, Whang KY.Opposite roles of MRF4 and MyoD in cell proliferation and myogenic differentiation. Biochem Biophys Res Commun. 2007 Dec 21;364(3):476-82. | ||
| + | * Jeon HM, Sohn YW, Oh SY, Kim SH, '''Beck S''', Kim S, Kim H. Inhibitor of differentiation 4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res. 2011 In press | ||
Latest revision as of 18:36, 6 April 2011
[edit] Educational background
- Post Doctoral research., Yonsei University Seoul, Korea, Department of Biotechnology (Supervisor: Professor Insuk Lee) (04/2011-Present)
- Ph.D., Seoul National University, School of Agricultural Bitechnology (Supervisor: Professor Yun-jaie Choi) (03/2004 - 02/2011)
Thesis Title: Development of Intelligent Drug Delivery System Targeting Brain Cancer Stem Cell Using Phage Display Technology
- B.Sc., Seoul National University, Department of Animal Biotechnology (03/1999 - 02/2004).
- Contact: beck310(at)gmail
[edit] Research Interests
- Tumor Development, Cancer Genomics, Systems Biology
[edit] Publications
- Beck S, Jin X, Sohn YW, Kim JK, Kim SH, Yin J, Pian X, Kim SC, Nam DH, Choi YJ, Kim H. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression. Mol Cells. 2010 Dec 24.
- Jin X*, Beck S*, Sohn YW, Kim JK, Kim SH, Yin J, Pian X, Kim SC, Choi YJ, Kim H. (*Equal contribution) Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor. Exp Mol Med. 2010 Aug 31;42(8):574-82.
- Jin X, Jeon HY, Joo KM, Kim JK, Jin J, Kim SH, Kang BG, Beck S, Lee SJ, Kim JK, Park AK, Park WY, Choi YJ, Nam DH, Kim H. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 2011 Mar 1. [Epub ahead of print]
- Yin J, Jin X, Beck S, Kang DH, Hong Z, Li Z, Jin Y, Zhang Q, Choi YJ, Kim SC, Kim H. In vitro myogenic and adipogenic differentiation model of genetically engineered bovine embryonic fibroblast cell lines. Biotechnol Lett. 2010 Feb;32(2):195-202.
- Jin X, Kim JG, Oh MJ, Oh HY, Sohn YW, Pian X, Yin JL, Beck S, Lee N, Son J, Kim H, Yan C, Wang JH, Choi YJ, Whang KY.Opposite roles of MRF4 and MyoD in cell proliferation and myogenic differentiation. Biochem Biophys Res Commun. 2007 Dec 21;364(3):476-82.
- Jeon HM, Sohn YW, Oh SY, Kim SH, Beck S, Kim S, Kim H. Inhibitor of differentiation 4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res. 2011 In press
